Register Now
Why register?
Login
 The leading web portal for pharmacy resources, news, education and careers February 9, 2010
Pharmacy Choice - Pharmaceutical News - Stocks That Stand Out For Nov. 4th, 2009 Are NVSR, AMLM, CHIP, XCHO, GDHI - February 9, 2010

Pharmacy News Article

 11/4/09 - Stocks That Stand Out For Nov. 4th, 2009 Are NVSR, AMLM, CHIP, XCHO, GDHI

Stocks That Standout For Nov. 4th, 2009 are NavStar Technologies, Inc. (PINKSHEETS: NVSR), American Lithium Minerals Inc. (OTCBB: AMLM), VeriChip Corporation (NASDAQ: CHIP), XenaCare Holdings, Inc. (OTCBB: XCHO), Golden Dragon Holdings, Inc. (OTCBB: GDHI)

Visit Us On Twitter and Facebook: http://twitter.com/StandoutStocks http://www.facebook.com/people/Standout-Stocks/547603354 Sign-up for our FREE Stock Alerts AND AWARD WINNING NEWSLETTER at HYPERLINK "http://www.Standoutstocks.com/" www.Standoutstocks.com -

NavStar Technologies, Inc. Issues a Shareholder Update

NavStar Technologies, Inc. Provides an Update on the Company's Focus for November and December 2009

ANAHEIM, CA, Nov 04, 2009 NavStar Technologies, Inc. (PINKSHEETS: NVSR), a firm focused on developing and commercializing multi-national asset tracking and monitoring devices for vehicles and high value cargo, today issued a shareholder update on several key initiative for the last 60 days of 2009.

Dear Shareholders, As you know, significant progress has been made this year to identify partners in several countries and to get distribution agreements signed. This effort, while time consuming and difficult, will result in purchase orders for NavStar products in late 2009 and first quarter of 2010. Below is an update on a few of the "near term" opportunities that will unfold in the next 60 to 90 days.

* The contract with the transportation department in Ecuador is in the final stages of the field trial and units will ship in early 2010. We are the vendor of choice and delays are due to personnel changes within the government of Ecuador.

* Final terms for a Joint Venture in Korea have been finalized and will be signed this month.

* A field trial with a US trucking company will begin in late November or early December.

* The opportunity that was announced in early October for distribution into the Middle East is still alive but taking much longer than expected to reach agreeable terms and conditions.

The effort to get a distribution agreement signed, conduct a field trial and get a purchase order takes time and has of course been more difficult given the current economic climate. In spite of these conditions we have established a diverse customer base and have 6 significant agreements in place as we conclude 2009 and start 2010.

For a more in-depth review of the company plans for the rest of 2009 and projections for 2010, look for an interview with NavStar's Chairman and CEO N. Douglas Pritt later today at www.tradergains.com.

About NavStar Technologies, Inc.

NavStar (www.navstarinc.com) is focused on the creation of products and services that provide tracking and monitoring of vehicles and high value cargo, equipment, and other valuable and personal assets.

American Lithium Minerals Appoints Chris Hobbs, CA, to the Position of CFO and as a Member of the Board of Directors

HENDERSON, NV, Nov 03, 2009 American Lithium Minerals Inc. (OTCBB: AMLM) (the "Company") announced today the appointment of Mr. Chris Hobbs, CA, to the position of CFO and as a member of the Board of Directors.

Stated Matthew Markin, Chairman of the Board for American Lithium Minerals: "We are extremely pleased to welcome Chris Hobbs to our growing company. His expertise in both the mining sector and mergers and acquisitions will be a tremendous asset as we continue the execution of our plan to be a dominant player in the domestic lithium and rare earth minerals arenas." Chris Hobbs, CA, will lead the finance team at American Lithium Minerals with a focus on mergers and acquisitions. Since leaving KPMG LLP Chartered Accountants, Mr. Hobbs has held numerous Chief Financial Officer Positions in both the public and private sectors and has had extensive experience in the investment banking sector. Mr. Hobbs is a co-founder of Pine Point Capital Advisors Inc. Pine Point specializes in providing financial advisory and mergers and acquisition services to companies in the mining and technology sectors. Prior to Pine Point, Mr. Hobbs was a member of the corporate finance team at Becher McMahon Capital Markets and Continua Capital Inc. where he focused on the investment banking and mergers and acquisitions services provided by the firms. Mr. Hobbs is a member of the Chartered Accountants of Ontario and holds a Bachelor of Business Administration Degree from the Schulich School of Business at York University.

About American Lithium Minerals American Lithium Minerals Inc. is an early stage lithium exploration company engaged in evaluating, developing and acquiring lithium projects, with a focus on the USA.

Forward-Looking Statements This current report contains "forward-looking statements," as that term is defined in Section 27A of the United States Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Statements in this press release which are not purely historical are forward-looking statements and include any statements regarding beliefs, plans, expectations or intentions regarding the future, including but not limited to, the Company becoming a dominant player in the domestic lithium and rare earth minerals arenas.

Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, the inherent uncertainties associated with mineral exploration and difficulties associated with obtaining financing on acceptable terms. We are not in control of lithium prices and these could vary to make development uneconomic. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements. Although we believe that the beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that such beliefs, plans, expectations or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also refer to the risk factors disclosure outlined in our most recent annual report for our last fiscal year, our quarterly reports, and other periodic reports filed from time-to-time with the Securities and Exchange Commission.

VeriChip Corporation Named Finalist for South Florida Business Journal 2009 Technology Awards

DELRAY BEACH, Fla., Nov 04, 2009 VeriChip Corporation ("VeriChip" or the "Company") (NASDAQ:CHIP) announced today that it has been selected as a finalist for the South Florida Business Journal's 2009 Technology Awards in the Hardware category. The South Florida Business Journal Technology Awards were created to honor the area's best technology-based companies, the CEOs or CIOs leading the way, and the companies making the best use of a technology in South Florida. The awards look for growing start-up companies, trendsetting innovations, products and services to highlight. The winners will be announced on Thursday, November 5, 2009.

Scott R. Silverman, VeriChip's Chairman and CEO, said, "It is an honor to be selected as a finalist in the hardware category for the 2009 Technology Awards. We believe that our VeriChip patient identification microchip as well as our products under development, including a glucose-sensing RFID microchip and a rapid virus detection system for the H1N1 virus and other forms of influenza, are products that can improve the standard of healthcare and therefore the lives of patients." About VeriChip Corporation VeriChip Corporation, headquartered in Delray Beach, Florida, has developed the VeriMed(TM) Health Link System for rapidly and accurately identifying people who arrive in an emergency room and are unable to communicate. This system uses the first human-implantable passive RFID microchip and corresponding personal health record, cleared for medical use in October 2004 by the United States Food and Drug Administration.

On September 8, 2009, VeriChip Corporation announced it agreed to acquire Steel Vault Corporation (OTCBB:SVUL) to form PositiveID Corporation. PositiveID will provide identification technologies and tools to protect consumers and businesses. The companies expect the merger to close in the fourth quarter of 2009.

For more information on VeriChip, please call 1-800-970-2447, or e-mail info@verichipcorp.com. Additional information can be found online at www.verichipcorp.com.

Statements about VeriChip's future expectations, including the likelihood that the Company will be a winner of the award, the ability of the microchip as well as other products under development to improve the standard of healthcare and therefore the lives of patients, the likelihood that the Company will successfully develop a glucose-sensing RFID microchip and a rapid virus detection system for the H1N1 virus and other forms of influenza, the likelihood that the merger will close in the fourth quarter of 2009 and all other statements in this press release other than historical facts are "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934, and as that term is defined in the Private Litigation Reform Act of 1995. Such forward-looking statements involve risks and uncertainties and are subject to change at any time, and VeriChip's actual results could differ materially from expected results. These risks and uncertainties include the Company's ability to successfully develop a glucose-sensing RFID microchip and a rapid virus detection system for the H1N1 virus and other forms of influenza, the timing and success of submission, acceptance and approval of required regulatory filings; as well as certain other risks. Additional information about these and other factors that could affect the Company's business is set forth in the Company's various filings with the Securities and Exchange Commission, including those set forth in the Company's 10-K filed on February 12, 2009, under the caption "Risk Factors." The Company undertakes no obligation to update or release any revisions to these forward-looking statements to reflect events or circumstances after the date of this statement or to reflect the occurrence of unanticipated events, except as required by law.

Additional Information and Where to Find It On September 8, 2009, VeriChip and Steel Vault issued a joint press release announcing the signing of an Agreement and Plan of Reorganization, among VeriChip, Steel Vault and VeriChip Acquisition Corp., a Delaware corporation and wholly-owned subsidiary of VeriChip (the "Acquisition Subsidiary"), pursuant to which the Acquisition Subsidiary will be merged with and into Steel Vault, with Steel Vault surviving and becoming a wholly-owned subsidiary of VeriChip (the "Merger"). Upon the consummation of the Merger, each outstanding share of Steel Vault's common stock will be converted into 0.5 shares of VeriChip common stock.

In connection with the Merger, VeriChip filed with the Securities and Exchange Commission ("SEC") a Registration Statement on Form S-4 that will contain a Joint Proxy Statement/Prospectus of VeriChip and Steel Vault. Investors and security holders are urged to read the Registration Statement and the Joint Proxy Statement/Prospectus carefully because they contain important information about VeriChip, Steel Vault and the proposed transaction. The Joint Proxy Statement/Prospectus and other relevant materials (when they become available), and any other documents filed with the SEC, may be obtained free of charge at the SEC's web site (www.sec.gov). In addition, investors and security holders may obtain a free copy of other documents filed by VeriChip or Steel Vault by directing a written request, as appropriate, to VeriChip at 1690 South Congress Avenue, Suite 200, Delray Beach, Florida 33445, Attention: Investor Relations, or to Steel Vault at 1690 South Congress Avenue, Suite 200, Delray Beach, Florida 33445, Attention: Investor Relations. Investors and security holders are urged to read the Joint Proxy Statement/Prospectus and the other relevant materials before making any voting or investment decision with respect to the proposed transaction.

VeriChip, Steel Vault and their respective directors and executive officers may be deemed to be participants in the solicitation of proxies in connection with the proposed transaction.

Information regarding the interests of these directors and executive officers in the proposed transaction will be included in the Joint Proxy Statement/Prospectus referred to above. Additional information regarding the directors and executive officers of VeriChip is also included in VeriChip's Form 10-K, which was filed with the SEC on February 12, 2009. Additional information regarding the directors and executive officers of Steel Vault is also included in Steel Vault's proxy statement (Form DEF 14A) for the 2009 annual meeting of Steel Vault's stockholders, which was filed with the SEC on February 9, 2009, as amended. These documents are available free of charge at the SEC's website (www.sec.gov) and by contacting Investor Relations at the addresses above.

XenaCare Holdings Announces Availability of Cobroxin through the Chain Drug Marketing Association (CDMA)

XenaCare Holdings has Announced That the Chain Drug Marketing Association (CDMA) Will Begin Taking Inventory of Cobroxin for Redistribution and Sale Through its 6,000 Member Pharmacies

DELRAY BEACH, Fla., Nov 04, 2009 XenaCare Holdings, Inc. (OTCBB: XCHO), a company specializing in the marketing and retail distribution of consumer healthcare products, has announced today that the Chain Drug Marketing Association (CDMA) will begin inventorying Cobroxin for redistribution to its member pharmacies. The CDMA currently has over 6,000 independent pharmacy members throughout the United States.

"As one of the largest pharmacy organizations in the United States, we are excited to be working with the CDMA to distribute Cobroxin to its independent pharmacy members," explained Frank Rizzo, President of XenaCare Holdings. "Having a presence in CDMA member pharmacies will help us build significant awareness about Cobroxin as we continue to expand the brand nationwide through retailers and our multimillion dollar national advertising campaign," he concluded.

Cobroxin is the first over-the-counter (OTC) pain reliever clinically proven to treat moderate to severe (Stage 2) chronic pain. The drug is available as an oral spray for treating lower back pain, migraines, neck aches, shoulder pain, cramps and neuralgia and as a topical gel for treating joint pain and pain associated with repetitive stress and arthritis.

Additional benefits to Cobroxin include: All Natural Non-Addictive Non-Narcotic Non-Opiate More Potent than Morphine Long Lasting XenaCare Holdings, which holds the exclusive license from Nutra Pharma Corporation (OTCBB: NPHC) to market and distribute Cobroxin in the United States, announced in October that it had begun accepting orders for Cobroxin online at Cobroxin.com. Additionally, the Company has recently begun distribution to online and brick-and-mortar retailers and will continue to announce locations where Cobroxin will be available for sale.

About XenaCare Holdings XenaCare Holdings, Inc. engages in the formulation, marketing, and distribution of nutrition supplement products primarily in the United States. In addition to Cobroxin for the treatment of moderate to severe (Stage 2) chronic pain, the Company's clinical products include XenaCor, which supports the lowering of serum cholesterol, C-reactive protein, and homocysteine levels to support cardiovascular health; XenaTri for lowering triglycerides and raising HDL to support cardiovascular health; and XenaZyme Plus that increases the body's oxygen carrying capacities designed to support digestion. XenaCare's clinical products also comprise body replenishment products. In addition, the company offers formulations for the lifestyle performance market, which consists of sports line for athletes, including SunPill that is formulated to protect the skin when exposed to damaging ultraviolet rays. XenaCare markets its products through the Internet, pharmacies, and doctors offices. The company was founded in 2001 and is based in Delray Beach, Florida.

http://www.XenaCareHoldings.com http://www.Cobroxin.com Cautionary Note Concerning Forward Looking Statements Except for the historical and present factual information contained herein, the matters set forth in this document, including statements regarding our plans to introduce Cobroxin into the commercial marketplace and for additional marketing campaigns are forward looking statements. Although these forward looking statements constitute our current plans, the timing, marketing channels and advertising support for the product may change. Investors are cautioned that these forward-looking statements are not guarantees of future performance. Actual events or results may differ from the Company's current plans. There are many risks, uncertainties and other factors that can prevent the achievement of our goals or cause results to differ from those expressed or implied by these forward-looking statements including, without limitation, the risks described in greater detail in filings made by the Company with the Securities and Exchange Commission. The Company assumes no obligation to publicly update or revise its forward-looking statements even if experience or future events make it clear that any of the anticipated results expressed or implied herein will not be realized. The Company's filings may be accessed at the SEC's Edgar system at www.sec.gov.

Golden Dragon Holdings Announces Current Information Status on the PINKSHEETS

BEIJING, Nov 04, 2009 Golden Dragon Holdings, Inc. (Other OTC: GDHI) www.gdfbhk.com is pleased to have completed the process for the Company to obtain "PS" status on PINKSHEETS. The company has filed all necessary disclosure and financial documents of information with PINKSHEETS, enabling GDHI to be fully transparent. The Board of Directors has moved to continue this level of full transparency in order to be quoted as "CURRENT INFORMATION" on "PINKSHEETS.COM." Frank Yglesias, GDHI CEO, said, "We are very excited to have achieved this goal of PS status on PINKSHEETS, and we are continuing our commitment to strive to reach each and every goal we set by the end of 2009." About Golden Dragon Holdings, Inc.

Golden Dragon Holdings, Inc. (PINKSHEETS: GDHI) is a publicly traded company that owns and operates Golden Dragon Food & Beverage Import & Export Company of Hong Kong, Ltd. (GDHK) in central Hong Kong and Beijing Flying Golden Dragon International Trading Co., Ltd in China (BFGD). Golden Dragon Holdings, Inc. has agreements with U.S. food manufacturers. GDHI acts as a buying agent for GDHK, negotiating vendor contracts and services with U.S. food and beverage industry partners. The Hong Kong Company plays a strategic role in the importation of products into the Chinese market by leveraging the Closer Economic Partnership Arrangement (CEPA) with China. Through this arrangement, Beijing Flying Golden Dragon International Trading Co., Ltd distributes some of the most popular U.S. food and beverage brand products directly into the hypermarkets, supermarkets and convenience stores in China. The Company is responsible for order fulfillment for its clients in China, as well as providing advertising and promotion (A&P) services for its U.S. food and beverage products.

Safe Harbor Statement Information in this press release may contain 'forward-looking statements.' Statements describing objectives or goals or the Company's future plans are also forward-looking statements and are subject to risks and uncertainties, including the financial performance of the Company and market valuations of its stock, which could cause actual results to differ materially from those anticipated. Forward-looking statements in this news release are made pursuant to the 'Safe Harbor' provisions of the United States Private Securities Litigation Reform Act of 1995.

About Standoutstocks.com www.Standoutstocks.com has become one of the premier stops for investors who wish to experience huge profits via investing in up-and-coming publicly traded companies.

www.Standoutstocks.com email report service is free to those investors who sign up on our website. The alert service is designed to notify investors of undervalued and often overlooked stocks. Subscribers are introduced to OTCBB and Pinksheet companies that have the potential of showing increased activity and Standing Out from the rest of the market. To subscribe to this free service, visit the Standout StocksReport home page at http://www.Standoutstocks.com and select the "join now" button.

Join us at http://www.standoutstocks.com for a complimentary subscription to the most exciting online financial newsletter on the market.

Disclaimer: Verify all claims and do your own due diligence. Standoutstocks.com profiles are not a solicitation or recommendation to buy, sell or hold securities. Standoutstocks.com is not offering securities for sale. An offer to buy or sell can be made only with accompanying disclosure documents and only in the states and provinces for which they are approved. All statements and expressions are the sole opinion of the editor and are subject to change without notice. Standoutstocks.com is not liable for any investment decisions by its readers or subscribers. It is strongly recommended that any purchase or sale decision be discussed with a financial adviser, or a broker-dealer, or a member of any financial regulatory bodies. The information contained herein has been provided as an information service only. The accuracy or completeness of the information is not warranted and is only as reliable as the sources from which it was obtained. It should be understood there is no guarantee that past performance will be indicative of future results. Investors are cautioned that they may lose all or a portion of their investment in this or any other company. In order to be in full compliance with the Securities Act of 1933, Section 17(b), Standoutstocks.com is owned and operated by Standoutstocks.com. Neither Standoutstocks.com nor any of its affiliates, or employees shall be liable to you or anyone else for any loss or damages from use of this e-mail, caused in whole or part by its negligence or contingencies beyond its control in procuring, compiling, interpreting, reporting, or delivering this Web Site or e-mail and any contents. Since Standoutstocks.com receives compensation and its employees or members of their families may hold stock in the profiled companies, there is an inherent conflict of interest in Standoutstocks.com statements and opinions and such statements and opinions cannot be considered independent. Standoutstocks.com and its management may benefit from any increase in the share prices of the profiled companies. Information contained herein contains "forward looking statements" within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities and Exchange Act of 1934. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions or future events or performance are not statements of historical facts and may be "forward looking statements". Forward looking statements are based on expectations, estimates and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Standoutstocks.com services are often paid for using free-trading shares. Standoutstocks.com may be selling shares of stock at the same time the profile is being disseminated to potential investors; this should be viewed as a definite conflict of interest and as such, the reader should take this into consideration.

Visit us for a full Disclaimer at: http://www.standoutstocks.com/disclaimer.aspx

((Comments on this story may be sent to info@m2.com))



(c) 2009 M2 COMMUNICATIONS

Pharmacy News Index
  Drug Delivery Systems
  Drugstores
  FDA Final Approvals
  Front Page Healthcare News
  Generic Drugs
  Hospital Industry
  Internet Pharmacy
  IT in Healthcare
  Medicare & Medicaid
  Over-the-Counter Drugs
  Pharm Industry Trends and Policy
  Pharmaceutical Development
  Pharmaceutical Industry

LIVE ONLINE CE

Last Chance
Feb 09: The Essentials of Pharmacy Malpractice
Feb 11: Medication Safety in Pregnancy & Lactation
Feb 17: 2009 in Review: New Drugs, Dosage Forms, Indications and Warnings
Feb 21: Malpractice Case Studies in Pharmacy
Feb 22: Update on the Comprehensive Management of COPD
Click for entire Webinar Calendar

Special Announcement

Free Membership
Click Here to register to Win an iPod nano.
Rules and Regulations
Enjoy Free CE, Drug Search, industry newsletters and more...

Nursing Jobs
Are you a nurse looking for a job?

Check out the Nursing Job Source.

Your number one choice for nursing jobs.



Websites » RxCareerCenter.comRxSchool.comRxProHealth.comRxTechSchool.comPharmacyPages.comNursingJobSource.comNurseZone.comRN.com
Copyright © 2009 Pharmacy Choice - All rights reserved.
Terms and Conditions | Privacy Statement
888-682-4415